Prosecution Insights
Last updated: August 18, 2026

Examiner: RODRIGUEZ, CRIS LOIREN

Tech Center 3700 • Art Units: 3732 3772 3783

This examiner grants 25% of resolved cases

Performance Statistics

25.1%
Allow Rate
-44.9% vs TC avg
224
Total Applications
+10.1%
Interview Lift
1219
Avg Prosecution Days
Based on 199 resolved cases, 2023–2026

Rejection Statute Breakdown

1.7%
§101 Eligibility
24.8%
§102 Novelty
46.9%
§103 Obviousness
23.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18693711 INTERLOCKED SENSOR ASSEMBLY FOR INFUSION SYSTEM Non-Final OA CareFusion 303, Inc.
18571825 COMPOSITIONS OF EXTENDED RELEASE COATINGS AND METHODS FOR APPLYING EXTENDED RELEASE COATINGS Non-Final OA Eli Lilly and Company
18585182 Auto-Injector With Assembly and Alignment Features Non-Final OA Becton, Dickinson and Company
18107866 CATHETER INSERTION DEVICE AND METHOD OF INSERTING A CATHETER Non-Final OA Becton, Dickinson and Company
17901041 Instrument Delivery Device with Nested Housing Non-Final OA Becton, Dickinson and Company
17506145 BODY CONFORMING WEARABLE DEVICE FOR PROVIDING OUTPUT AND INPUT FOR A DRUG DELIVERY SYSTEM Final Rejection Insulet Corporation
18694104 Electronics Device with Battery Life Optimisation Provided for a drug delivery device or a drug delivery add-on device Non-Final OA Sanofi
18016995 ELECTRONIC SYSTEM FOR A DRUG DELIVERY DEVICE AND DRUG DELIVERY DEVICE Non-Final OA Sanofi
19171829 ACTIVATION SYSTEM FOR A SUPPLEMENTAL DEVICE ATTACHED TO A MEDICAMENT DELIVERY DEVICE Non-Final OA SHL MEDICAL AG
18687964 Activation sleeve and subassembly for a medicament delivery device Non-Final OA SHL Medical AG
17916075 INDWELLING NEEDLE Final Rejection NIPRO CORPORATION
18181226 NEEDLE-FREE INJECTOR, ASSOCIATED RELOADABLE AND DISPOSABLE NOZZLES, AND METHODS OF INJECTION Non-Final OA The Children's Hospital of Philadelphia
17855349 Side-Port Injection Devices For Use With Electroporation, and Related Systems and Methods Final Rejection Inovio Pharmaceuticals, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month